Cargando…

Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening

Skin infections caused by drug-resistant Staphylococcus aureus occur at high rates nationwide. Mouse primary epidermal organoids (mPEOs) possess stratified histological and morphological characteristics of epidermis and are highly similar to their derived tissue at the transcriptomic and proteomic l...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaorui, Tong, Xuebo, Li, Zhihong, Cheng, Quan, Wang, Xiaowei, Long, Yin, Liu, Fangbo, Wang, Yonghui, Wang, Juan, Liu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833019/
https://www.ncbi.nlm.nih.gov/pubmed/36631452
http://dx.doi.org/10.1038/s41419-022-05525-x
_version_ 1784868171559206912
author Xie, Xiaorui
Tong, Xuebo
Li, Zhihong
Cheng, Quan
Wang, Xiaowei
Long, Yin
Liu, Fangbo
Wang, Yonghui
Wang, Juan
Liu, Li
author_facet Xie, Xiaorui
Tong, Xuebo
Li, Zhihong
Cheng, Quan
Wang, Xiaowei
Long, Yin
Liu, Fangbo
Wang, Yonghui
Wang, Juan
Liu, Li
author_sort Xie, Xiaorui
collection PubMed
description Skin infections caused by drug-resistant Staphylococcus aureus occur at high rates nationwide. Mouse primary epidermal organoids (mPEOs) possess stratified histological and morphological characteristics of epidermis and are highly similar to their derived tissue at the transcriptomic and proteomic levels. Herein, the susceptibility of mPEOs to methicillin-resistant S. aureus USA300 infection was investigated. The results show that mPEOs support USA300 colonization and invasion, exhibiting swollen epithelial squamous cells with nuclear necrosis and secreting inflammatory factors such as IL-1β. Meanwhile mPEOs beneficial to observe the process of USA300 colonization with increasing infection time, and USA300 induces mPEOs to undergo pyroptosis and autophagy. In addition, we performed a drug screen for the mPEO infection model and showed that vancomycin restores cell viability and inhibits bacterial internalization in a concentration-dependent manner. In conclusion, we establish an in vitro skin infection model that contributes to the examination of drug screening strategies and antimicrobial drug mechanisms.
format Online
Article
Text
id pubmed-9833019
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98330192023-01-12 Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening Xie, Xiaorui Tong, Xuebo Li, Zhihong Cheng, Quan Wang, Xiaowei Long, Yin Liu, Fangbo Wang, Yonghui Wang, Juan Liu, Li Cell Death Dis Article Skin infections caused by drug-resistant Staphylococcus aureus occur at high rates nationwide. Mouse primary epidermal organoids (mPEOs) possess stratified histological and morphological characteristics of epidermis and are highly similar to their derived tissue at the transcriptomic and proteomic levels. Herein, the susceptibility of mPEOs to methicillin-resistant S. aureus USA300 infection was investigated. The results show that mPEOs support USA300 colonization and invasion, exhibiting swollen epithelial squamous cells with nuclear necrosis and secreting inflammatory factors such as IL-1β. Meanwhile mPEOs beneficial to observe the process of USA300 colonization with increasing infection time, and USA300 induces mPEOs to undergo pyroptosis and autophagy. In addition, we performed a drug screen for the mPEO infection model and showed that vancomycin restores cell viability and inhibits bacterial internalization in a concentration-dependent manner. In conclusion, we establish an in vitro skin infection model that contributes to the examination of drug screening strategies and antimicrobial drug mechanisms. Nature Publishing Group UK 2023-01-11 /pmc/articles/PMC9833019/ /pubmed/36631452 http://dx.doi.org/10.1038/s41419-022-05525-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Xie, Xiaorui
Tong, Xuebo
Li, Zhihong
Cheng, Quan
Wang, Xiaowei
Long, Yin
Liu, Fangbo
Wang, Yonghui
Wang, Juan
Liu, Li
Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening
title Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening
title_full Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening
title_fullStr Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening
title_full_unstemmed Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening
title_short Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening
title_sort use of mouse primary epidermal organoids for usa300 infection modeling and drug screening
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833019/
https://www.ncbi.nlm.nih.gov/pubmed/36631452
http://dx.doi.org/10.1038/s41419-022-05525-x
work_keys_str_mv AT xiexiaorui useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening
AT tongxuebo useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening
AT lizhihong useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening
AT chengquan useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening
AT wangxiaowei useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening
AT longyin useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening
AT liufangbo useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening
AT wangyonghui useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening
AT wangjuan useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening
AT liuli useofmouseprimaryepidermalorganoidsforusa300infectionmodelinganddrugscreening